Sarclisa Specified Drug Use Investigation (Monotherapy / with Dexamethasone / with Carfilzomib and Dexamethasone) (Relapsed or refractory multiple myeloma)
Not Applicable
Recruiting
- Conditions
- Relapsed or refractory multiple myeloma
- Registration Number
- JPRN-UMIN000047806
- Lead Sponsor
- Sanofi K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 86
Inclusion Criteria
Not provided
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety (Adverse Drug Reaction)
- Secondary Outcome Measures
Name Time Method Effectiveness